SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
Authors
Keywords
-
Journal
Oncogenesis
Volume 6, Issue 7, Pages e360
Publisher
Springer Nature
Online
2017-07-10
DOI
10.1038/oncsis.2017.53
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma
- (2016) Ananya Roy et al. PLoS One
- Neoadjuvant Therapy for Breast Cancer
- (2015) Dimitrios Zardavas et al. Annual Review of Medicine
- Targeting HER2 for the Treatment of Breast Cancer
- (2015) Mothaffar F. Rimawi et al. Annual Review of Medicine
- Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells
- (2015) Sangmin Kim et al. CYTOKINE
- Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
- (2015) Shabnam Shalapour et al. NATURE
- Clinical management of breast cancer heterogeneity
- (2015) Dimitrios Zardavas et al. Nature Reviews Clinical Oncology
- Active CREB1 Promotes a Malignant TGF 2 Autocrine Loop in Glioblastoma
- (2014) L. Rodon et al. Cancer Discovery
- In vitroreconstitution of complexes between pro-matrix metalloproteinase-9 and the proteoglycans serglycin and versican
- (2013) Nabin Malla et al. FEBS Journal
- Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
- (2013) Lu He et al. MEDICAL ONCOLOGY
- Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells
- (2013) Angeliki Korpetinou et al. PLoS One
- Serglycin in Health and Diseases
- (2012) Olivia J. Scully et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma
- (2012) C.S. Scanlon et al. JOURNAL OF DENTAL RESEARCH
- Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes Metastasis
- (2011) X.-J. Li et al. CANCER RESEARCH
- MicroRNAs as regulators of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. CELL CYCLE
- Serglycin: A Structural and Functional Chameleon with Wide Impact on Immune Cells
- (2011) Svein O. Kolset et al. JOURNAL OF IMMUNOLOGY
- CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
- (2010) Y. Xu et al. CANCER RESEARCH
- Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma
- (2010) Antonis Skliris et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started